|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 84.44 USD | -0.02% |
|
+0.62% | +81.40% |
| Market Cap | 8.96B 7.76B 7.28B 6.64B 12.49B 855B 12.69B 85.69B 33.45B 428B 33.62B 32.9B 1,427B | P/E 2026 * |
-18.1x | P/E 2027 * | -20.6x |
|---|---|---|---|---|---|
| Enterprise Value | 7.92B 6.87B 6.44B 5.87B 11.04B 756B 11.22B 75.79B 29.59B 378B 29.74B 29.09B 1,262B | EV / Sales 2026 * |
135x | EV / Sales 2027 * | 44.8x |
| Free-Float |
98.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Crinetics Pharmaceuticals, Inc.
| 1 day | -0.02% | ||
| 1 week | +0.62% | ||
| Current month | +1.10% | ||
| 1 month | +0.92% | ||
| 3 months | +125.29% | ||
| 6 months | +97.75% | ||
| Current year | +81.40% |
| 1 week | 83.96 | 84.71 | |
| 1 month | 83.47 | 84.71 | |
| Current year | 32.3 | 84.71 | |
| 1 year | 28.73 | 84.71 | |
| 3 years | 15.76 | 84.71 | |
| 5 years | 15.23 | 84.71 | |
| 10 years | 10.63 | 84.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/7/26 | Fiscal year | Founder | 39,856 | 0.0378% | ||
| 7/2/26 | Sell | Director | -3,000 | 0.0028% | ||
| 3/12/26 | Sell | Director | 5,000 | 0.0048% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.02% | +0.62% | +180.62% | +411.29% | 8.96B | ||
| +2.07% | +13.76% | +65.44% | +106.53% | 71.56B | ||
| -1.72% | -2.83% | +33.24% | +62.24% | 54.43B | ||
| -4.50% | -4.69% | +2.82% | +463.22% | 27.59B | ||
| -1.27% | -1.57% | +46.46% | +6.09% | 23.91B | ||
| -0.67% | +1.02% | -18.32% | -13.84% | 23.14B | ||
| +0.35% | +1.35% | +38.91% | -20.08% | 18.65B | ||
| +0.35% | +12.02% | +257.19% | +466.50% | 18.64B | ||
| -0.95% | -3.52% | +20.04% | +613.01% | 16.01B | ||
| +0.46% | -3.05% | +31.49% | +135.18% | 12.54B | ||
| Average | -0.59% | +3.72% | +65.79% | +223.01% | 27.54B | |
| Weighted average by Cap. | -0.40% | +3.54% | +54.86% | +171.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.81M 50.98M 47.79M 43.57M 81.99M 5.61B 83.3M 563M 220M 2.81B 221M 216M 9.37B | 181M 157M 147M 134M 252M 17.24B 256M 1.73B 675M 8.63B 678M 664M 28.79B |
| Net income | -507M -440M -412M -376M -707M -48.43B -719M -4.86B -1.9B -24.24B -1.91B -1.86B -80.87B | -463M -402M -377M -343M -646M -44.23B -656M -4.43B -1.73B -22.14B -1.74B -1.7B -73.86B |
| Net Debt | -1.04B -897M -841M -767M -1.44B -98.78B -1.47B -9.9B -3.87B -49.45B -3.89B -3.8B -165B | -865M -750M -703M -641M -1.21B -82.57B -1.23B -8.28B -3.23B -41.33B -3.25B -3.18B -138B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | US$84.44 | -0.02% | 1,289,231 |
| 26-08-12 | US$84.46 | +0.12% | 2,583,863 |
| 26-08-11 | US$84.36 | +0.25% | 1,422,042 |
| 26-08-10 | US$84.15 | +0.08% | 2,330,195 |
| 26-08-07 | US$84.08 | +0.19% | 1,941,776 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions

















